4
Shared Docs
4
Same-Page
4 / 4
Mentions
The Final Frontier? Inhibitor Cocktails to Stamp out Cancer The use of mutation-specific. inhibitor drugs to fight cancer has been growing in popularity around the wor
ound the world. In fact. over the last ten years. the prescription rate of inhibitors over cytotoxic chemotherapy has more than tripled according to the National Institute of Cancer. Indeed in 2004. the Journal of Oncology published a revealing table with cytotoxic chemotherapy as the sole treatment: the 5-year survival rate was
The Final Frontier? Inhibitor Cocktails to Stamp out Cancer The use of mutation-specific. inhibitor drugs to fight cancer has been growing in popularity around the wor
ound the world. In fact. over the last ten years. the prescription rate of inhibitors over cytotoxic chemotherapy has more than tripled according to the National Institute of Cancer. Indeed in 2004. the Journal of Oncology published a revealing table with cytotoxic chemotherapy as the sole treatment: the 5-year survival rate was
The Final Frontier? Inhibitor Cocktails to Stamp out Cancer The use of mutation-specific, inhibitor drugs to fight cancer has been growing in popularity around the wor
und the world. In fact, over the last ten years, the prescription rate of inhibitors over cytotoxic chemotherapy has more than tripled according to the National Institute of Cancer. Cytotoxic chemotherapies are simply not targeted enough to most cancer cells and still too detrimental to the body as a whole. Indeed, in 2004, the
The Final Frontier? Inhibitor Cocktails to Stamp out Cancer The use of mutation-specific. inhibitor drugs to fight cancer has been growing in popularity around the wor
ound the world. In fact, over the last ten years. the prescription rate of inhibitors over cytotoxic chemotherapy has more than tripled according to the National Institute of Cancer. Indeed in 2004. the Journal of Oncology published a revealing table with cytotoxic chemotherapy as the sole treatment: the 5-year survival rate was
Entities connected to both The Final Frontier and the National Institute of Cancer
Vogelstein
PERSONthe Program for Evolutionary Dynamics
ORGANIZATION
Martin Nowak
PERSON
Jeffrey Epstein
PERSONJohns Hopkins University School of Medicine
ORGANIZATIONBert Vogelstein
PERSONMassachusetts General
ORGANIZATIONthe lYinzetor of the Ludwig Center for Cancer Genetics
PERSONNenvak
PERSONthe Journal of Oncology
ORGANIZATION
Johns Hopkins
ORGANIZATIONJournal of Oncology
ORGANIZATIONa Biology and Mathematics
ORGANIZATIONJohns I Iopkins
ORGANIZATIONtrials pandit&
ORGANIZATIONEGER TX
PERSON